Cigna Investments Inc. New Sells 68 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cigna Investments Inc. New lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% in the fourth quarter, HoldingsChannel.com reports. The firm owned 9,428 shares of the healthcare conglomerate’s stock after selling 68 shares during the quarter. UnitedHealth Group comprises approximately 0.8% of Cigna Investments Inc. New’s holdings, making the stock its 16th largest holding. Cigna Investments Inc. New’s holdings in UnitedHealth Group were worth $4,769,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Wealthcare Capital Partners LLC bought a new stake in UnitedHealth Group in the 4th quarter worth about $20,352,000. Sovran Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $1,375,000. Compound Global Advisors LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at $1,144,000. Peterson Wealth Services raised its holdings in UnitedHealth Group by 1.7% during the 4th quarter. Peterson Wealth Services now owns 3,733 shares of the healthcare conglomerate’s stock valued at $1,888,000 after buying an additional 63 shares during the period. Finally, Stonebridge Financial Group LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $5,426,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on UNH shares. Bank of America dropped their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Up 1.2 %

Shares of NYSE UNH opened at $533.17 on Tuesday. The firm has a market cap of $490.66 billion, a price-to-earnings ratio of 34.40, a PEG ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock’s 50-day simple moving average is $529.18 and its 200-day simple moving average is $564.40. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm earned $5.83 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.